Get access

Pathogenesis of hepatic encephalopathy

Authors

  • DIETER HÄUSSINGER,

    Corresponding author
    1. Clinic for Gastroenterology, Hepatology und Infectiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
      Prof D. Häussinger, Medizinische Universitätsklinik, Moorenstrasse 5, 40225 Düsseldorf, Germany. Email: haeussin@uni-duesseldorf.de
    Search for more papers by this author
  • FREIMUT SCHLIESS,

    1. Clinic for Gastroenterology, Hepatology und Infectiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
    Search for more papers by this author
  • GERALD KIRCHEIS

    1. Clinic for Gastroenterology, Hepatology und Infectiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
    Search for more papers by this author

Prof D. Häussinger, Medizinische Universitätsklinik, Moorenstrasse 5, 40225 Düsseldorf, Germany. Email: haeussin@uni-duesseldorf.de

Abstract

Abstract  Hepatic encephalopathy (HE) is a neuropsychiatric syndrome during the course of acute or chronic liver disease. It is functional in nature, potentially reversible and precipitated by rather heterogeneous factors. At the neurophysiological level HE is characterized by a low frequent cortico-cortical electrical coupling, which may explain the cognitive deficits and a low frequent corticomuscular coupling, which may explain the fine motor deficits. Current evidence suggests that HE is the consequence of a low grade chronic glial edema with subsequent alterations of glioneuronal communication. Different factors, such as ammonia, benzodiazepines, inflammatory cytokines can induce or aggravate astrocyte swelling, which results in the activation of osmosignaling cascades, protein modifications, alterations in gene expression and neurotransmission. Among the protein modifications nitration of critical tyrosine residues in glial proteins may play an important role. Several proteins, which are nitrated in response to ammonia, benzodiazepines, hypoosmotic astrocyte swelling or inflammatory cytokines have been identified, inluding glutamine synthetase and the peripheral type benzodiazepine receptor.

© 2002 Blackwell Publishing Asia Pty Ltd

Get access to the full text of this article

Ancillary